A detailed history of Jennison Associates LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Jennison Associates LLC holds 2,039,644 shares of BSX stock, worth $180 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,039,644
Previous 1,219,320 67.28%
Holding current value
$180 Million
Previous $83.5 Million 88.09%
% of portfolio
0.1%
Previous 0.06%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$67.33 - $77.71 $55.2 Million - $63.7 Million
820,324 Added 67.28%
2,039,644 $157 Million
Q1 2024

May 02, 2024

SELL
$57.6 - $68.62 $490,348 - $584,162
-8,513 Reduced 0.69%
1,219,320 $83.5 Million
Q4 2023

Feb 01, 2024

BUY
$48.64 - $57.81 $758,589 - $901,604
15,596 Added 1.29%
1,227,833 $71 Million
Q3 2023

Oct 31, 2023

BUY
$50.19 - $54.68 $5.37 Million - $5.86 Million
107,093 Added 9.69%
1,212,237 $64 Million
Q2 2023

Aug 03, 2023

BUY
$49.72 - $54.64 $1.15 Million - $1.26 Million
23,098 Added 2.13%
1,105,144 $59.8 Million
Q1 2023

Apr 26, 2023

BUY
$45.09 - $50.03 $48.8 Million - $54.1 Million
1,082,046 New
1,082,046 $54.1 Million
Q2 2021

Aug 12, 2021

SELL
$38.58 - $44.24 $30.9 Million - $35.4 Million
-801,037 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$35.27 - $39.67 $36.9 Million - $41.5 Million
-1,047,114 Reduced 56.66%
801,037 $31 Million
Q4 2020

Feb 05, 2021

SELL
$33.15 - $41.97 $182 Million - $230 Million
-5,483,346 Reduced 74.79%
1,848,151 $66.4 Million
Q3 2020

Nov 04, 2020

SELL
$34.44 - $42.23 $56.9 Million - $69.7 Million
-1,650,753 Reduced 18.38%
7,331,497 $280 Million
Q2 2020

Aug 06, 2020

SELL
$30.19 - $39.11 $244 Million - $316 Million
-8,085,569 Reduced 47.37%
8,982,250 $315 Million
Q1 2020

May 06, 2020

BUY
$25.83 - $45.71 $147 Million - $261 Million
5,709,360 Added 50.27%
17,067,819 $557 Million
Q4 2019

Feb 07, 2020

BUY
$37.87 - $45.37 $361 Million - $433 Million
9,545,336 Added 526.46%
11,358,459 $514 Million
Q3 2019

Nov 08, 2019

SELL
$40.31 - $43.45 $7.15 Million - $7.71 Million
-177,487 Reduced 8.92%
1,813,123 $73.8 Million
Q2 2019

Aug 06, 2019

SELL
$34.91 - $42.98 $391,131 - $481,547
-11,204 Reduced 0.56%
1,990,610 $0
Q1 2019

May 10, 2019

BUY
$32.91 - $40.75 $12,374 - $15,322
376 Added 0.02%
2,001,814 $76.8 Million
Q4 2018

Feb 06, 2019

BUY
$31.73 - $39.04 $61,365 - $75,503
1,934 Added 0.1%
2,001,438 $70.7 Million
Q3 2018

Nov 08, 2018

BUY
$32.83 - $38.63 $529,252 - $622,754
16,121 Added 0.81%
1,999,504 $77 Million
Q2 2018

Aug 02, 2018

BUY
$26.84 - $34.32 $961,757 - $1.23 Million
35,833 Added 1.84%
1,983,383 $64.9 Million
Q1 2018

Apr 20, 2018

BUY
$25.2 - $28.54 $5.31 Million - $6.02 Million
210,832 Added 12.14%
1,947,550 $53.2 Million
Q4 2017

Jan 25, 2018

SELL
$24.79 - $29.8 $160 Million - $192 Million
-6,443,302 Reduced 78.77%
1,736,718 $43.1 Million
Q3 2017

Nov 03, 2017

BUY
$26.26 - $29.17 $215 Million - $239 Million
8,180,020
8,180,020 $239 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $126B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.